News Conference News The Structural Heart Disease Summit 2018 Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli Michael O'Riordan June 26, 2018
Presentation The Structural Heart Disease Summit 2018 Early and Late PFO Closure Complications Presenter: John D. Carroll, Brij Maini, Zahid Amin June 23, 2018
Presentation The Structural Heart Disease Summit 2018 Basic and Advanced PFO Closure Techniques Presenter: John D. Carroll, Brij Maini June 23, 2018
Presentation The Structural Heart Disease Summit 2018 The Spectrum of PFO Closure Devices: Similarities and Meaningful Differences Presenter: John D. Carroll, Brij Maini June 23, 2018
Presentation The Structural Heart Disease Summit 2018 Beyond Iatrogenic Stroke: PFO Closure for Migraine and More Presenter: John D. Carroll, Brij Maini, Robert J. Sommer June 23, 2018
Presentation The Structural Heart Disease Summit 2018 Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines Presenter: John D. Carroll, Brij Maini, Lars Sondergaard June 23, 2018
Presentation The Structural Heart Disease Summit 2018 Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
News Conference News The Structural Heart Disease Summit 2018 Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year Michael O'Riordan June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Societal Impact of Access Restrictions to TAVR: Viewpoint From The Canadian Health Technology Assessment (HTA) Agency Presenter: Randolph P. Martin, Mark J. Russo, Harindra Wijeysundera June 21, 2018